Free Trial

Zhengye Biotechnology (ZYBT) News Today

$4.62 -0.38 (-7.60%)
As of 02/21/2025 04:00 PM Eastern
Zhengye Biotechnology Holding Limited stock logo
Zhengye Biotechnology Holding Limited's (NASDAQ:ZYBT) Quiet Period Will Expire on February 17th
Zhengye Biotechnology's (NASDAQ:ZYBT - Get Free Report) quiet period is set to end on Monday, February 17th. Zhengye Biotechnology had issued 1,500,000 shares in its IPO on January 7th. The total size of the offering was $6,000,000 based on an initial share price of $4.00. During the company's quiet period, insiders and any underwriters involved in the IPO are prevented from issuing any research reports or earnings estimates for the company because of SEC regulations. Following the expiration of the company's quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.
Get Zhengye Biotechnology News Delivered to You Automatically

Sign up to receive the latest news and ratings for ZYBT and its competitors with MarketBeat's FREE daily newsletter.

ZYBT Media Mentions By Week

ZYBT Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ZYBT
News Sentiment

0.00

0.60

Average
Medical
News Sentiment

ZYBT News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ZYBT Articles
This Week

0

1

ZYBT Articles
Average Week

Get Zhengye Biotechnology News Delivered to You Automatically

Sign up to receive the latest news and ratings for ZYBT and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:ZYBT) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners